ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: DETAILED SAFETY ANALYSIS FROM THE RANDOMIZED PHASE 3 HERO STUDY

被引:0
|
作者
Mehlhaff, Bryan
Shore, Neal D.
George, Daniel J.
Cookson, Michael S.
Saltzstein, Daniel R.
Tutrone, Ronald
Bailen, James L.
Brown, Bruce
Langenberg, Andria G. M.
Fallick, Mark
Lu, Sophia
Hanson, Sarah
Tombal, Bertrand
Saad, Fred
机构
来源
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP27-16
引用
收藏
页码:E456 / E456
页数:1
相关论文
共 50 条
  • [31] RELUGOLIX VS LEUPROLIDE EFFECTS ON CASTRATION RESISTANCE-FREE SURVIVAL FROM THE PHASE 3 HERO STUDY IN MEN WITH ADVANCED PROSTATE CANCER
    Saad, Fred
    George, Daniel
    Cookson, Michael
    Saltzstein, Daniel
    Tutrone, Ronald
    Akaza, Hideyuki
    Bossi, Alberto
    Brown, Bruce
    Selby, Bryan
    Lu, Sophia
    Walling, Jackie
    Tombal, Bertrand
    Shore, Neal
    JOURNAL OF UROLOGY, 2021, 206 : E414 - E414
  • [32] Phase 3 HERO Trial Finds Relugolix to Be Superior to Leuprolide in Prostate Cancer
    Slater, Hannah
    ONCOLOGY-NEW YORK, 2020, 34 (07): : 252 - 253
  • [33] Depression and androgen-deprivation therapy for advanced prostate cancer
    Savard, Josee
    Simard, Sebastian
    Hervouet, Severine
    Ivers, Hans
    Rioux, Dominique
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S89 - S89
  • [34] Role of radiation and androgen deprivation therapy for advanced prostate cancer
    Jani, Ashesh B.
    Rossi, Peter J.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 41 - 47
  • [35] Depression and androgen-deprivation therapy for advanced prostate cancer
    Savard, J.
    Simard, S.
    Hervouet, S.
    Ivers, H.
    Rioux, D.
    PSYCHO-ONCOLOGY, 2007, 16 (09) : S151 - S152
  • [36] Re: Combined Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced Prostate Cancer: A Randomised, Phase 3 Trial
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2012, 188 (03): : 810 - 810
  • [37] Re: Combined Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced Prostate Cancer: A Randomised, Phase 3 Trial
    Saad, Fred
    EUROPEAN UROLOGY, 2012, 62 (05) : 932 - 933
  • [38] Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer
    Saad, Fred
    George, Daniel J.
    Cookson, Michael S.
    Saltzstein, Daniel R.
    Tutrone, Ronald
    Bossi, Alberto
    Brown, Bruce
    Selby, Bryan
    Lu, Sophia
    Tombal, Bertrand
    Shore, Neal D.
    CANCERS, 2023, 15 (19)
  • [39] Plain language review: the safety of relugolix combination therapy for advanced prostate cancer
    De La Cerda, Jose
    Thorley, Jared
    Sieber, Paul
    Cookson, Michael S.
    Flanders, Scott C.
    Gatoulis, Sergio C.
    Shore, Neal D.
    FUTURE ONCOLOGY, 2025, 21 (01) : 51 - 62
  • [40] Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis
    Tsai, Huei-Ting
    Penson, David F.
    Makambi, Kepher H.
    Lynch, John H.
    Van den Eeden, Stephen K.
    Potosky, Arnold L.
    UROLOGY, 2013, 82 (02) : 327 - 333